PATENT CLAIM ANALYSIS

Application Number: 16012417
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["424", "489000"]

Abstract:
The present invention provides pharmaceutical formulations of lyophilized bendamustine suitable for pharmaceutical use. The present invention further provides methods of producing lyophilized bendamustine. The pharmaceutical formulations can be used for any disease that is sensitive to treatment with bendamustine, such as neoplastic diseases.

Claim (Index 5):
The pharmaceutical composition of  claim 1  containing less than or equal to about 4.0% (area percent of bendamustine) of bendamustine degradants.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 94.0
- Lexical Diversity: 1.46875
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13969724', '11330868', '13654898', '13719379', '13719409']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8104915650503696
- 35 USC 102 Novelty (BERT): 0.5589237790369231
- Combined Prediction Score: 0.7853347864490249
- Mean Citation Score: 415.457802
- Max Citation Score: 440.6927
- Similarity Product: 361.2340211882114

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test